导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.19% | 2904/4773 |
| 近一周 | -1.20% | 2272/5467 |
| 近一月 | -2.62% | 1011/5421 |
| 近一季 | -6.41% | 2034/5238 |
| 近半年 | -4.07% | 2874/4931 |
| 近一年 | -0.21% | 2646/4400 |
| 近两年 | 36.15% | 2055/2954 |
| 近三年 | 22.47% | 1372/2253 |
| 成立以来 | 83.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.57% 1849/4961 |
7.91% 2646/5312 |
- - |
- - |
| 2025 | 13.05% 2666/4813 |
0.55% 1819/3635 |
2.72% 1401/4076 |
7.17% 3470/4524 |
2.13% 1074/4813 |
| 2024 | 16.37% 819/3463 |
2.51% 768/2808 |
-1.06% 911/3014 |
16.13% 1529/3129 |
-1.19% 1620/3463 |
| 2023 | -3.37% 635/2656 |
5.12% 825/2280 |
-2.22% 567/2385 |
-0.84% 454/2515 |
-5.19% 1286/2655 |
| 2022 | -13.83% 345/2207 |
-10.77% 420/1919 |
3.89% 1079/2016 |
-10.99% 481/2113 |
4.43% 547/2208 |
| 2021 | -2.92% 879/1822 |
-1.23% 452/1255 |
1.85% 1034/1330 |
-8.63% 1146/1466 |
5.61% 281/1822 |
| 2020 | 34.38% 440/1250 |
-8.09% 588/1028 |
13.94% 582/1067 |
12.65% 375/1164 |
13.91% 324/1184 |
| 2019 | 43.89% 183/1092 |
25.55% 456/754 |
0.12% 195/804 |
4.84% 179/850 |
9.18% 249/918 |
| 2018 | -23.34% 276/834 |
- - |
- - |
- - |
-13.46% 536/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 招商央视财经50指数C VS. 长安沪深300非周期A(740101) |